Rigel Pharmaceuticals (RIGL) Gains from Investment Securities (2010 - 2025)
Rigel Pharmaceuticals' quarterly Gains from Investment Securities came in at $1.4 million in Q3 2025, down 7.39% year-on-year from $1.5 million in Q3 2024, and up 0.85% quarter-over-quarter from $1.4 million in Q2 2025.
Rigel Pharmaceuticals has reported Gains from Investment Securities for 16 years, with the latest figure at $1.4 million in Q3 2025.
- For the quarter ending Q3 2025, Gains from Investment Securities fell 7.39% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (up 32.57% YoY), and the FY2025 full-year result was $1.1 million, up 48.23% from the prior year.
- Gains from Investment Securities for Q3 2025 stood at $1.4 million, up from $1.4 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $13.1 million in Q3 2023, with the low at -$510000.0 in Q1 2022.
- Average Gains from Investment Securities over 5 years is $4.9 million, with a median of $1.4 million recorded in 2024.
- Peak annual rise in Gains from Investment Securities reached 1669.23% in 2022, while the deepest fall reached 8400.0% in 2022.
- Tracing RIGL's Gains from Investment Securities over 5 years: stood at $39000.0 in 2021, then jumped by 1669.23% to $690000.0 in 2022, then tumbled by 75.94% to $166000.0 in 2023, then soared by 331.99% to $717106.0 in 2024, then jumped by 96.34% to $1.4 million in 2025.
- The last three Gains from Investment Securities figures came in at $1.4 million (Q3 2025), $1.4 million (Q2 2025), and $1.2 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.41 Mn |
| Sep 30, 2025 | 1.41 Mn |
| Jun 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 1.40 Mn |
| Mar 31, 2025 | 1.22 Mn |
| Mar 31, 2025 | 1.22 Mn |
| Dec 31, 2024 | 717,106.00 |
| Dec 31, 2024 | 717,106.00 |
| Sep 30, 2024 | 1.52 Mn |
| Sep 30, 2024 | 1.52 Mn |
| Jun 30, 2024 | 1.41 Mn |
| Jun 30, 2024 | 1.41 Mn |
| Mar 31, 2024 | 7.13 Mn |
| Mar 31, 2024 | 7.13 Mn |
| Dec 31, 2023 | 166,000.00 |
| Dec 31, 2023 | 166,000.00 |
| Sep 30, 2023 | 13.15 Mn |
| Sep 30, 2023 | 13.15 Mn |
| Jun 30, 2023 | 12.19 Mn |
| Jun 30, 2023 | 12.19 Mn |
| Mar 31, 2023 | 7.65 Mn |
| Mar 31, 2023 | 7.65 Mn |
| Dec 31, 2022 | 690,000.00 |
| Dec 31, 2022 | 690,000.00 |
| Sep 30, 2022 | 12.35 Mn |
| Sep 30, 2022 | 12.35 Mn |
| Jun 30, 2022 | 11.94 Mn |
| Jun 30, 2022 | 11.94 Mn |
| Mar 31, 2022 | -510,000.00 |
| Mar 31, 2022 | -510,000.00 |
| Dec 31, 2021 | 39,000.00 |
| Dec 31, 2021 | 39,000.00 |
| Sep 30, 2021 | 10.40 Mn |
| Sep 30, 2021 | 10.40 Mn |
| Jun 30, 2021 | 10.38 Mn |
| Jun 30, 2021 | 10.38 Mn |
| Mar 31, 2021 | -6,000.00 |
| Mar 31, 2021 | -6,000.00 |
| Dec 31, 2020 | 4,000.00 |
| Dec 31, 2020 | 4,000.00 |
| Sep 30, 2020 | 13.99 Mn |
| Sep 30, 2020 | 13.99 Mn |
| Jun 30, 2020 | 11.01 Mn |
| Jun 30, 2020 | 11.01 Mn |
| Mar 31, 2020 | -35,000.00 |
| Mar 31, 2020 | -35,000.00 |
| Dec 31, 2019 | 1,000.00 |
| Dec 31, 2019 | 1,000.00 |
| Sep 30, 2019 | 16.83 Mn |
| Sep 30, 2019 | 16.83 Mn |
| Jun 30, 2019 | 10.56 Mn |
| Jun 30, 2019 | 10.56 Mn |
| Mar 31, 2019 | 10.64 Mn |
| Mar 31, 2019 | 10.64 Mn |
| Dec 31, 2018 | 83,000.00 |
| Dec 31, 2018 | 83,000.00 |
| Sep 30, 2018 | 2.59 Mn |
| Sep 30, 2018 | 2.59 Mn |
| Jun 30, 2018 | 14.60 Mn |
| Jun 30, 2018 | 14.60 Mn |
| Mar 31, 2018 | 10.54 Mn |
| Mar 31, 2018 | 10.54 Mn |
| Dec 31, 2017 | -34,000.00 |
| Dec 31, 2017 | -34,000.00 |
| Sep 30, 2017 | 11.45 Mn |
| Sep 30, 2017 | 11.45 Mn |
| Jun 30, 2017 | 10.24 Mn |
| Jun 30, 2017 | 10.24 Mn |
| Mar 31, 2017 | -33,000.00 |
| Mar 31, 2017 | -33,000.00 |
| Dec 31, 2016 | -37,000.00 |
| Dec 31, 2016 | -37,000.00 |
| Sep 30, 2016 | 200,000.00 |
| Sep 30, 2016 | 200,000.00 |
| Jun 30, 2016 | 700,000.00 |
| Jun 30, 2016 | 700,000.00 |
| Mar 31, 2016 | 700,000.00 |
| Mar 31, 2016 | 700,000.00 |
| Dec 31, 2015 | -107,000.00 |
| Dec 31, 2015 | -107,000.00 |
| Sep 30, 2015 | 1.18 Mn |
| Sep 30, 2015 | 1.18 Mn |
| Jun 30, 2015 | 1.18 Mn |
| Jun 30, 2015 | 1.18 Mn |
| Mar 31, 2015 | 1.18 Mn |
| Mar 31, 2015 | 1.18 Mn |
| Dec 31, 2014 | -325,000.00 |
| Dec 31, 2014 | -325,000.00 |
| Sep 30, 2014 | 950,000.00 |
| Sep 30, 2014 | 950,000.00 |
| Jun 30, 2014 | 950,000.00 |
| Jun 30, 2014 | 950,000.00 |
| Mar 31, 2014 | 700,000.00 |
| Mar 31, 2014 | 700,000.00 |
| Dec 31, 2013 | -58,000.00 |
| Dec 31, 2013 | -58,000.00 |
| Sep 30, 2013 | 3.03 Mn |
| Sep 30, 2013 | 3.03 Mn |
| Jun 30, 2013 | 2.11 Mn |
| Jun 30, 2013 | 2.11 Mn |
| Mar 31, 2013 | 2.02 Mn |
| Mar 31, 2013 | 2.02 Mn |
| Dec 31, 2012 | -67,000.00 |
| Dec 31, 2012 | -67,000.00 |
| Sep 30, 2012 | 2.14 Mn |
| Sep 30, 2012 | 2.14 Mn |
| Jun 30, 2012 | 2.13 Mn |
| Jun 30, 2012 | 2.13 Mn |
| Mar 31, 2012 | -59,000.00 |
| Mar 31, 2012 | -59,000.00 |
| Dec 31, 2011 | -59,000.00 |
| Dec 31, 2011 | -59,000.00 |
| Sep 30, 2011 | 2.23 Mn |
| Sep 30, 2011 | 2.23 Mn |
| Jun 30, 2011 | 2.22 Mn |
| Jun 30, 2011 | 2.22 Mn |
| Mar 31, 2011 | 55,000.00 |
| Mar 31, 2011 | 55,000.00 |
| Dec 31, 2010 | -56,000.00 |
| Dec 31, 2010 | -56,000.00 |
| Sep 30, 2010 | -79,000.00 |
| Sep 30, 2010 | -79,000.00 |